Please login to the form below

Not currently logged in
Email:
Password:

F-star appoints GSK's Neil Brewis

He joins the UK antibody firm as its chief scientific officer
F-Star

Cambridge-based antibody research company F-Star has appointed Dr Neil Brewis as chief scientific officer. 

Brewis joins from GlaxoSmithKline where he served as vice president and head head of biopharmaceutical research, leading a global team of 300 scientists who advanced numerous monoclonal antibodies, antibody fragments, and protein therapeutics from target validation into early clinical development.

He said: “F-Star is an emerging world leader in bispecfic antibody drug discovery and I am delighted to join the company at this exciting time to help maximise the potential of the technology and progress compounds clinical development.”

Brewis also has 20 years of experience in drug discovery and development prior to joining GSK.

John Haurum CEO of F-Star, said: “We are very pleased to welcome Neil to our team. His significant track record and expertise in applying antibody technologies to discover and develop clinical products will further enable us to move our portfolio of immuno-oncology compounds into the clinic.

“This appointment strengthens our experienced management team and supports F-star's strategy to lead the bispecific antibody space in immuno-oncology.

“It also demonstrates the unmatched attraction of Cambridge as the foremost biotech cluster in Europe, serving as a key hub for biopharmaceutical companies and academic excellence within antibody drug discovery and development.”

5th November 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics